Loading
NL
Nova Leap Health Corp. Stock: price and insider trades · Canada
CA·Mcap CA$39.7M
Nova Leap Health Corp.: what insiders have been doing
Every trade that managers of Nova Leap Health Corp. disclose to SEDI is tracked on this page. Over the twelve months to 18 October 2026, 11 filings were filed, from 3 insiders.
Not one open-market sale was filed. On the buying side, 3 insiders reported 10 purchases totalling €45k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €12k, the purchase published on 8 June 2026 by LeBlanc, Christopher Thomas Francis is the largest of the period. Among those who bought: 3 senior executives.
Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 11 filings, this issuer sits right on that mark. Looking back to 2026, when coverage begins, insiders filed 10 purchases and no sales.
The most recent open-market purchase was published on 1 October 2026, 16 days ago. The median gap between a trade and its publication by SEDI is 1 day. The shorter that gap, the sooner other investors can see what insiders have done.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€45,000
10 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleR. Wayne Myles7 buys
Christopher Thomas Francis LeBlanc2 buys
Anne Whelan1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,278 of 24,148 companies
37.2
score / 100
Value32
Quality43
FCF yld3.9%
Earn yld-0.5%
EV/EBITDA40.6x
ROE7.1%
Gross mgn40%
Net mgn-0.6%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.46
Analyst consensus
Income statement
RevenueCA$31.5M
Gross profitCA$12.5M40% margin
EBITDACA$1.1M3% margin
Net income-CA$189.9k4.0% margin
Valuation
PER (trailing)22.8x
P/Book1.4x
Beta1.58
Balance sheet & cash
Market capCA$39.7M
Total debtCA$2.9M
Free Cash FlowCA$1.6M
Debt / Equity23%
Profitability & ownership
ROE7.1%
ROA4.4%
% insiders42.0%
% institutions0.0%
Last declaration on 1 October 2026
Declarations11 total
5,000 shares@ CA$0.5610.0063% mcap100.0% of flowCommon SharesTSXSEDI:4784055
Canonical exit: 24 Dec 2026 (T+90)
Common SharesTSXSEDI:4784053
16,500 shares@ CA$0.49220.016% mcap16.3% of flowCommon SharesTSXSEDI:4763957
Canonical exit: 10 Nov 2026 (T+90)
33,000 shares@ CA$0.49460.033% mcap32.8% of flowCommon SharesTSXSEDI:4763955
Canonical exit: 10 Nov 2026 (T+90)
2,500 shares@ CA$0.4950.0025% mcap2.5% of flowCommon SharesTSXSEDI:4763951
Canonical exit: 10 Nov 2026 (T+90)
1,000 shares@ CA$0.4950.0010% mcap1.0% of flowCommon SharesTSXSEDI:4763950
Canonical exit: 10 Nov 2026 (T+90)
13,500 shares@ CA$0.4950.013% mcap13.4% of flowCommon SharesTSXSEDI:4763948
Canonical exit: 10 Nov 2026 (T+90)
8,500 shares@ CA$0.4950.0085% mcap8.5% of flowCommon SharesTSXSEDI:4763944
Canonical exit: 10 Nov 2026 (T+90)
25,500 shares@ CA$0.4950.025% mcap25.4% of flowCommon SharesTSXSEDI:4763942
Canonical exit: 10 Nov 2026 (T+90)
50,000 shares@ CA$0.3895.5% of flowCommon SharesTSXSEDI:4731638
Canonical exit: 6 Sept 2026 (T+90)
2,471 shares@ CA$0.364.5% of flowCommon SharesTSXSEDI:4731636
Canonical exit: 3 Sept 2026 (T+90)
11 of 11 declarations
About Nova Leap Health Corp.
Nova Leap Health Corp. is a Canadian company focused on providing home care services. It aims to enhance the quality of life for individuals requiring in-home support.
